Abstract
We designed and synthesized novel PPARδ antagonists based on the crystal structure of the PPARδ full agonist TIPP-204 bound to the PPARδ ligand-binding domain, in combination with our nuclear receptor helix 12 folding modification hypothesis. Representative compound 3a exhibits PPARδ-preferential antagonistic activity.
Original language | English |
---|---|
Pages (from-to) | 6595-6599 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 19 |
Issue number | 23 |
DOIs | |
Publication status | Published - Dec 1 2009 |
Externally published | Yes |
Keywords
- Biphenylcarboxylic acid
- PPAR
- PPARδ
- PPARδ antagonist
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry